Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptide
Quick Overview for Fanconi Anemia, Complementation Group L (FANCL) (Middle Region) Peptide (ABIN8100442)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- FANCL Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-FANCL antibody ( ARP56321_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
-
Background
-
Background Information: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FAN
Alternative Symbols: FAAP43, FLJ10335, PHF9, POG
-
Molecular Weight
- 42kDa
-
Gene ID
- 55120
-
NCBI Accession
- NP_001108108
-
UniProt
- Q9NW38
Target
-